James Spellmeyer
Director of Finance/CFO at Sequoia Vaccines, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin B. Bacon | M | 59 |
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 1 years |
| William C. Rusnack | M | 79 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 3 years |
| Joseph P. Conran | M | 78 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 5 years |
| Michael Holmes | M | 65 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 3 years |
| Stephen M. Notestine | M | 74 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 3 years |
| Michael J. Mertz | M | 53 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 3 years |
| James P. Bick | M | 63 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 3 years |
| Brian Salmo | M | 42 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | 1 years |
| Jennifer Lynn Harris | M | 58 |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Schneider | M | 72 |
Pricewaterhouse LLP
| 10 years |
| David Joseph Gilbert | M | 66 |
Pricewaterhouse LLP
| 2 years |
| Linda Catrett Brotherton | F | - |
Pricewaterhouse LLP
| - |
| Alex Topping | M | - |
Pricewaterhouse LLP
| 3 years |
| Gregory Irace | M | 65 |
Pricewaterhouse LLP
| - |
| David Blackley | M | 62 |
Pricewaterhouse LLP
| - |
| Sunil K. Bhatia | M | - |
Pricewaterhouse LLP
| 7 years |
| Brian Bales | M | 61 |
Pricewaterhouse LLP
| 2 years |
| Daniel J. Vogel | M | - |
Pricewaterhouse LLP
| 4 years |
| John Robert Caldon | M | - |
Pricewaterhouse LLP
| 5 years |
| Steven L. Beal | M | 65 |
Pricewaterhouse LLP
| 7 years |
| Charles M. Urbain | M | 70 |
Pricewaterhouse LLP
| 4 years |
| Colleen Johnston | F | 65 |
Pricewaterhouse LLP
| - |
| David Barr | M | 60 |
Pricewaterhouse LLP
| 4 years |
| Robert Joseph Fitzsimmons | M | - |
Pricewaterhouse LLP
| 2 years |
| Bob J. McParland | M | - |
Pricewaterhouse LLP
| 10 years |
| John Donahue | M | 74 |
Pricewaterhouse LLP
| 13 years |
| Richard S. Davis | M | 65 |
Pricewaterhouse LLP
| 11 years |
| Daniel J. Hammond | M | - |
Pricewaterhouse LLP
| 10 years |
| Cameron B. Olson | M | 60 |
Pricewaterhouse LLP
| 9 years |
| Barry W. Stewart | M | - |
Pricewaterhouse LLP
| 5 years |
| Jack E. Kime | M | - |
Pricewaterhouse LLP
| 10 years |
| Stephen P. Gibson | M | 58 |
Pricewaterhouse LLP
| 7 years |
| Mary Ritchie | F | 67 |
Pricewaterhouse LLP
| 9 years |
| Janice Hess | F | 65 |
Pricewaterhouse LLP
| 2 years |
| Lester S. Fuwa | M | - |
Pricewaterhouse LLP
| 9 years |
| Robert Shaw | M | - |
Pricewaterhouse LLP
| 5 years |
| Jerry R. Banks | M | - |
Pricewaterhouse LLP
| 2 years |
| Ted McNamara | M | - |
Pricewaterhouse LLP
| 8 years |
| Richard Allen Bennett | M | - |
Pricewaterhouse LLP
| 6 years |
| W. Baxter | M | - |
Pricewaterhouse LLP
| 4 years |
| Ned Shadek | M | - |
Pricewaterhouse LLP
| 3 years |
| John Elder | M | - |
Pricewaterhouse LLP
| 9 years |
| J. S. Gamble | M | - |
Pricewaterhouse LLP
| 6 years |
| Anthony Lyddane | M | - |
Pricewaterhouse LLP
| - |
| James Drury | M | - |
Pricewaterhouse LLP
| 4 years |
| Kenneth A. Rosevear | M | 74 |
Pricewaterhouse LLP
| 15 years |
| John Kolling | M | - |
Pricewaterhouse LLP
| 12 years |
| Leo Daniel Martinic | M | - |
Pricewaterhouse LLP
| 3 years |
| Rick Sayles | M | - |
Pricewaterhouse LLP
| 4 years |
| Doug S. Soifer | M | - |
Pricewaterhouse LLP
| 7 years |
| Paul Knollmeyer | M | - |
Pricewaterhouse LLP
| 5 years |
| Steven R. Saltzman | M | 60 |
Pricewaterhouse LLP
| 3 years |
| Larry J. Abston | M | - |
Pricewaterhouse LLP
| - |
| Wallace R. Cooney | M | 61 |
Pricewaterhouse LLP
| 12 years |
| Clinton W. Walker | M | 61 |
Pricewaterhouse LLP
| 9 years |
| Lennert J. Leader | M | - |
Pricewaterhouse LLP
| 4 years |
| Bernard F. Pliska | M | 62 |
Pricewaterhouse LLP
| 11 years |
| Kevin Parker | M | 64 |
Pricewaterhouse LLP
| 5 years |
| Robert D. Shallish | M | 74 |
Pricewaterhouse LLP
| 12 years |
| Jose Seneca David | M | - |
Pricewaterhouse LLP
| 5 years |
| William Schafer | M | 66 |
Pricewaterhouse LLP
| 9 years |
| Walter Jagodinski | M | 67 |
Pricewaterhouse LLP
| 5 years |
| Christopher Cragg | M | 62 |
Pricewaterhouse LLP
| 10 years |
| Walter Rakowich | M | 66 |
Pricewaterhouse LLP
| 4 years |
| D. Wray | M | 63 |
Pricewaterhouse LLP
| 10 years |
| Troy L. Hester | M | 68 |
Pricewaterhouse LLP
| 8 years |
| Robert Henry Joseph | M | 76 |
Pricewaterhouse LLP
| 13 years |
| Joseph A. Boyle | M | 69 |
Pricewaterhouse LLP
| 14 years |
| Richard Liem | M | 70 |
Pricewaterhouse LLP
| 11 years |
| Patricia Maleski | F | 64 |
Pricewaterhouse LLP
| 13 years |
| James A. Tuell | M | 64 |
Pricewaterhouse LLP
| 13 years |
| Charles Dannewitz | M | 69 |
Pricewaterhouse LLP
| 14 years |
| Anthony J. Verkruyse | M | 65 |
Pricewaterhouse LLP
| 11 years |
| Maria Christina van der Sluijs-Plantz | F | - |
Pricewaterhouse LLP
| - |
| Christine B. Mead | F | 67 |
Pricewaterhouse LLP
| 9 years |
| John J. Gallagher | M | 60 |
Pricewaterhouse LLP
| 8 years |
| Joseph P. Joseph | M | - |
Pricewaterhouse LLP
| 5 years |
| Gail Hanson | F | - |
Pricewaterhouse LLP
| - |
| Thomas Lewis | M | 61 |
Pricewaterhouse LLP
| 14 years |
| Lawrence Judge | M | - |
Pricewaterhouse LLP
| 3 years |
| Charles J. Bello | M | - |
Pricewaterhouse LLP
| 3 years |
| Kenneth J. Cichocki | M | 70 |
Pricewaterhouse LLP
| 5 years |
| Brian Mark Pribyl | M | 65 |
Pricewaterhouse LLP
| 7 years |
| Dennis James Simonis | M | 67 |
Pricewaterhouse LLP
| 6 years |
| Martin M. Kovacich | M | - |
Pricewaterhouse LLP
| 14 years |
| Archie Black | M | 61 |
Pricewaterhouse LLP
| 3 years |
| Brian Kilb | M | - |
Pricewaterhouse LLP
| 3 years |
| Gérald Gagnon | M | - |
Pricewaterhouse LLP
| 3 years |
| Jeffrey B. Hewson | M | - |
Pricewaterhouse LLP
| - |
| Elizabeth Boland | F | 63 |
Pricewaterhouse LLP
| 9 years |
| Ian John Brookes | M | 62 |
Pricewaterhouse LLP
| - |
| James R. Fisher | M | 69 |
Pricewaterhouse LLP
| - |
| Russ J. Bell | M | - |
Pricewaterhouse LLP
| 4 years |
| Michael D. Matte | M | 65 |
Pricewaterhouse LLP
| 11 years |
| John D. Diederich | M | 71 |
Pricewaterhouse LLP
| 11 years |
| Donald Rober Bessler | M | - |
Pricewaterhouse LLP
| 5 years |
| Charles Peters | M | 72 |
Pricewaterhouse LLP
| 9 years |
| Gregory Abel | M | 61 |
Pricewaterhouse LLP
| 8 years |
| Michael J. Welsh | M | - |
Pricewaterhouse LLP
| 5 years |
| John C. Rogers | M | 63 |
Pricewaterhouse LLP
| 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Spellmeyer
- Personal Network
